Literature DB >> 8694661

How safe are folic acid supplements?

N R Campbell1.   

Abstract

Periconceptual use of folic acid supplements by women is effective in preventing neural tube defects in the fetus. Folic acid supplements also may prevent atherosclerosis and some malignant neoplasms. Nevertheless, safety concerns have delayed recommendations to increase folic acid consumption by the general population. Among the potential safety issues of folic acid supplementation are (1) difficulty identifying cobalamin deficiency, precipitation of neurologic complications of cobalamin deficiency, and lowering of cobalamin levels; (2) folate neurotoxicity; (3) antagonism of drugs that inhibit folate metabolism; (4) reduced zinc absorption; (5) association with malignant neoplasms; (6) hypersensitivity reactions; and (7) increased susceptibility to malaria. The data that suggest that folic acid supplements are unsafe are weak and consist predominantly of case series and reports. Nevertheless, greater difficulty diagnosing cobalamin deficiency due to "masking" of hematologic abnormalities by folic acid is a potential risk. Strict vegetarians need to be informed that they are at risk of cobalamin deficiency. Physicians need to be aware that routine hematologic indexes have a low sensitivity for cobalamin deficiency, especially in patients who are receiving folic acid supplements. Because no high-quality data exclude specific adverse effects, physicians should be vigilant in identifying detrimental effects when patients increase their consumption of folic acid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694661

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

Review 1.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Folate: a magic bullet or a double edged sword for colorectal cancer prevention?

Authors:  Y-I Kim
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

3.  Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1998-03-21

Review 4.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function.

Authors:  Anna E Stanhewicz; W Larry Kenney
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

5.  Association between lower hair zinc levels and neural tube defects.

Authors:  M Srinivas; D K Gupta; S S Rathi; J K Grover; V Vats; J D Sharma; D K Mitra
Journal:  Indian J Pediatr       Date:  2001-06       Impact factor: 1.967

Review 6.  Dietary Intervention for Preventing Colorectal Cancer: A Practical Guide for Physicians.

Authors:  Sang Hoon Kim; Jeong Yeon Moon; Yun Jeong Lim
Journal:  J Cancer Prev       Date:  2022-09-30

7.  Assessing cancer prevention studies--a matter of time.

Authors:  Bettina F Drake; Graham A Colditz
Journal:  JAMA       Date:  2009-11-18       Impact factor: 56.272

8.  High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials.

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2009-03

9.  Folic acid in pregnancy and mortality from cancer and cardiovascular disease: further follow-up of the Aberdeen folic acid supplementation trial.

Authors:  Caroline M Taylor; Charlotte Atkinson; Chris Penfold; Sohinee Bhattacharya; Doris Campbell; George Davey Smith; Sam Leary; Andy Ness
Journal:  J Epidemiol Community Health       Date:  2015-04-08       Impact factor: 3.710

10.  Folate augmentation of treatment - evaluation for depression (FolATED): protocol of a randomised controlled trial.

Authors:  Seren Haf Roberts; Emma Bedson; Dyfrig Hughes; Keith Lloyd; David B Menkes; Stuart Moat; Munir Pirmohamed; Gary Slegg; Johannes Thome; Richard Tranter; Rhiannon Whitaker; Clare Wilkinson; Ian Russell
Journal:  BMC Psychiatry       Date:  2007-11-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.